Biotech entity
Every one of those 2 sits in a single category, pharma. Xtampza ER is most often covered alongside Collegium Pharmaceutical, Inc., which appears in 2 of these 2 stories. The 17-day window averages about 0.8 stories each week. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window.
Last mentioned: Mar 15, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, pharma. Xtampza ER is most often covered alongside Collegium Pharmaceutical, Inc., which appears in 2 of these 2 stories. The 17-day window averages about 0.8 stories each week. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 6. This profile follows 2 Biotech stories mentioning Xtampza ER across the period from February 27, 2026 to March 15, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 184 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Xtampza ER. Shared-story counts are live from our verified record — not editorial picks.
Eventide Asset Management LLC has reduced its position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant remaining stake valued at $83.65 million. This institutional shift comes as Collegium continues to integrate recent acquisitions and navigate the complex regulatory landscape of the specialty pain management market.
Collegium Pharmaceutical's Q4 2025 results showcase a successful strategic shift toward diversification, led by the ADHD treatment Jornay PM. Simultaneously, CRA International’s earnings highlight a surging demand for specialized life sciences consulting amid a complex regulatory landscape.
Source: insidermonkey.com · insidermonkey.com
Xtampza ER is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
